The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
The recent run of good fortune for vaccine maker Novavax (NASDAQ:NVAX continues. Following the major licensing deal with ...
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination ...
A Novavax shareholder that had been waging a campaign to oust three board members at the Gaithersburg company has now ...
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
If you'd invested $10,000 in Novavax a year ago, right now, you'd have $15,200. And here's even better news: The Sanofi ...
Aventis S.A. ADR (SNY-Q) from The Globe and Mail including charting and trades.
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller ...
Novavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company. This withdrawal is in ...